Fluorescent Probe Traces Sphingolipid Trafficking Pathways
Author Information
Author(s): Steffen Steinert, Esther Lee, Guillaume Tresset, Dawei Zhang, Ralf Hortsch, Richard Wetzel, Sarita Hebbar, Jeyapriya Raja Sundram, Sashi Kesavapany, Elke Boschke, Rachel Kraut
Primary Institution: Institute of Bioengineering and Nanotechnology, A*Star, Singapore
Hypothesis
The study investigates the intracellular trafficking of a novel sphingolipid-binding fluorescent probe, the SBD peptide.
Conclusion
The SBD peptide is a useful tool for analyzing sphingolipid trafficking in disease models, as its binding and trafficking are sensitive to cholesterol levels.
Supporting Evidence
- SBD binds preferentially to raft-like lipid mixtures containing sphingomyelin, cholesterol, and complex gangliosides.
- SBD's uptake and trafficking route is distinct from that of non-raft markers like Transferrin.
- SBD's trafficking is significantly disrupted by cholesterol perturbations.
- SBD shows high colocalization with endolysosomal markers, indicating its pathway through these compartments.
- SBD can be used in both mammalian and Drosophila neurons, making it versatile for studying lipid trafficking.
Takeaway
Researchers created a special probe to track how certain fats move inside cells, which can help us understand diseases better.
Methodology
The study used synthetic membrane binding assays and quantitative time-course colocalization in live cells to analyze the SBD peptide's interactions and trafficking.
Limitations
The study does not address the long-term effects of SBD on cellular functions or its behavior in different cell types beyond those tested.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website